Monday, June 14

Coronavirus vaccine: India to begin world’s biggest drive

But concerns have been raised over the efficacy of Covaxin because the

regulator’s emergency approval came before the completion of Phase 3 clinical trials. The regulator and the manufacturer have said the vaccine is safe, and that the efficacy data would be available by February.

Source link


Leave a Reply

Your email address will not be published.

Call Now